| Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial … PA Zimmerman, A Buckler-White, G Alkhatib, T Spalding, J Kubofcik, ... Molecular medicine 3, 23-36, 1997 | 543 | 1997 |
| Assessment of systemic lupus erythematosus GKW Lam, M Petri Clinical and experimental rheumatology 23 (5), S120, 2005 | 277 | 2005 |
| Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis ML Harris, E Darrah, GK Lam, SJ Bartlett, JT Giles, AV Grant, P Gao, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 179 | 2008 |
| Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis JT Giles, M Szklo, W Post, M Petri, RS Blumenthal, G Lam, AC Gelber, ... Arthritis research & therapy 11, 1-12, 2009 | 167 | 2009 |
| Efficacy and safety of etanercept in the treatment of scleroderma-associated GK Lam, LK Hummers, A Woods, FM Wigley The Journal of Rheumatology 34 (7), 1636-1637, 2007 | 116 | 2007 |
| Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab BG Feagan, G Lam, C Ma, GR Lichtenstein Alimentary Pharmacology & Therapeutics 49 (1), 31-40, 2019 | 93 | 2019 |
| Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. OJ Cohen, M Vaccarezza, GK Lam, BF Baird, K Wildt, PM Murphy, ... The Journal of clinical investigation 100 (6), 1581-1589, 1997 | 59 | 1997 |
| Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies OJ Cohen, G Pantaleo, GK Lam, AS Fauci Springer seminars in immunopathology 18, 305-322, 1997 | 53 | 1997 |
| Association of high serum Interleukin‐6 levels with severe progression of rheumatoid arthritis and increased treatment response differentiating Sarilumab from adalimumab or … A Boyapati, S Schwartzman, J Msihid, E Choy, MC Genovese, ... Arthritis & Rheumatology 72 (9), 1456-1466, 2020 | 38 | 2020 |
| Nut man TB, Murphy PM 1997. Inherited resistance to HIV 1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with con trasting clinical … PA Zimmerman, A Buckler White, G Alkhatib, T Spalding, J Kubofcik, ... Mol. Med 3, 23-36, 0 | 15 | |
| 069 High baseline serum IL-6 identifies a subgroup of rheumatoid arthritis patients with rapid joint damage and clinical progression and predicts increased sarilumab treatment … A Boyapati, J Msihid, S Schwartzman, E Choy, GR Burmester, G Lam, ... Rheumatology 58 (Supplement_3), kez106. 068, 2019 | 9 | 2019 |
| Round 4: Citrullinated proteins, peptidylarginine deiminase (PAD), and rheumatoid arthritis G Lam Baltimore, MD: Johns Hopkins, Arthritis Center, 2006 | 4 | 2006 |
| Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic … AJ Laster, GK Lam, HS Gladue, AA Kashif, EP Siceloff, VD Lackey, ... RMD open 8 (1), e002203, 2022 | 2 | 2022 |
| Immunogenicity of COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic diseases (AIIRDs) G Lam, A Laster, S McCarter, H Gladue, A Kashif, E Siceloff, V Lackey, ... Arthritis & Rheumatology, 2013-2016, 2021 | 2 | 2021 |
| Does adjustment to dosing and timing of immunomodulatory drugs impact immunogenicity of COVID19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)? A Laster, G Lam, S McCarter, H Gladue, A Kashif, E Siceloff, V Lackey, ... Arthritis & Rheumatology, 3228-3231, 2021 | 1 | 2021 |
| Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting JF Baker, C Bakewell, A Dikranian, G Lam, J O’Brien, PC Moore, M Yu, ... Rheumatology and Therapy 11 (3), 841-853, 2024 | | 2024 |
| Immunogenicity of COVID-19 Vaccines in Patients with Autoimmune and Inflammatory Rheumatic Diseases (AIIRD) on Immunomodulatory Therapies (IMT): An Updated Cohort Study G Lam, A Laster, H Gladue, A Kashif, E Siceloff, V Lackey, C Robertson, ... ARTHRITIS & RHEUMATOLOGY 74, 1510-1513, 2022 | | 2022 |
| Clinical and Demographic Characteristics of Patients with RF plus/ACPA plus RA and First-Line TNF Inhibitor versus Abatacept Treatment Choice in Real-World Clinical Practice G Lam, H Zheng, E Bland, V Patel, L N'Dri, P Asgarisabet, K Wittstock, ... ARTHRITIS & RHEUMATOLOGY 74, 2792-2793, 2022 | | 2022 |
| Domains Contributing to Minimal Disease Activity Non-Achievement in Patients with Psoriatic Arthritis Receiving Golimumab: Post Hoc Analysis of a Phase 3, Randomized, Double … A Kavanaugh, G Lam, LS Tam, N Shiff, Y Lee, AMB Perdomo, M Shawi, ... ARTHRITIS & RHEUMATOLOGY 74, 4170-4172, 2022 | | 2022 |
| Reactive Arthritis 18 GK Lam, CO Bingham III CURRENT Diagnosis & Treatment in Rheumatology, 183, 2012 | | 2012 |
